Medicare Drug Price Negotiations Yield $12 Billion Savings on 15 Key Medications
New Medicare drug price negotiations under the Inflation Reduction Act cut costs for 15 major medications, saving Medicare $12 billion annually.
New Medicare drug price negotiations under the Inflation Reduction Act cut costs for 15 major medications, saving Medicare $12 billion annually.
Explore critical insights on Medicare enrollment and coverage choices as the deadline nears, emphasizing strategic selection of Medicare Advantage plans from industry expert Amanda Weigel.
Joshua Meeks of Blue Cross Blue Shield of Michigan offers expert advice on selecting Medicare plans that balance cost and coverage. Discover strategic insights into optimizing individual Medicare coverage.
Rising Medicare Advantage plan terminations in Maine drive unprecedented demand for enrollment assistance, highlighting resource constraints amid complex federal and provider changes impacting seniors' health coverage.
Explore how Medicare beneficiaries can maximize vision benefits, understand coverage details, and manage costs with Medicare Advantage and supplemental plans, plus standalone vision insurance options like VSP.
Humana appeals CMS Medicare Advantage star ratings dispute as federal courts and regulatory changes reshape payer compliance and bonus structures in the MA market.
CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.
Understand critical factors for selecting Medicare Advantage plans in 2026, including costs, provider networks, supplemental benefits, and CMS star ratings, to optimize coverage and budget during fall open enrollment.
Explore the significance of Medicare Advantage in managing healthcare expenses for seniors and people with disabilities, focusing on diabetes care and insulin affordability.
Insights from the 2025 Payer + Provider Summit on AI-driven care, value-based models, community partnerships, and the need for stable federal policies to advance primary and preventive care.